Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Daniel Leisman, M.D.

Concepts (180)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Daniel Leisman's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Daniel Leisman has written about over time.
Isotonic Solutions, 1 publications between 2017 and 2017, average publication date September 2017. Resuscitation, 3 publications between 2016 and 2019, average publication date October 2017. Hypotension, 3 publications between 2017 and 2018, average publication date February 2018. Critical Illness, 5 publications between 2016 and 2021, average publication date June 2018. Hospital Mortality, 7 publications between 2016 and 2023, average publication date June 2018. Shock, Septic, 6 publications between 2016 and 2023, average publication date August 2018. Intensive Care Units, 5 publications between 2017 and 2020, average publication date March 2019. Sepsis, 14 publications between 2016 and 2024, average publication date August 2019. Renin-Angiotensin System, 5 publications between 2017 and 2022, average publication date January 2021. Angiotensin II, 2 publications between 2020 and 2022, average publication date August 2021. Endothelium, 1 publications between 2022 and 2022, average publication date February 2022. Pulmonary Alveoli, 1 publications between 2022 and 2022, average publication date February 2022. Myeloid Cells, 1 publications between 2022 and 2022, average publication date August 2022.

To see the data from this visualization as text, click here.
Leisman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (180)
Explore
_
Co-Authors (17)
Explore
_
Similar People (59)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.